Skip to main content

Table 1 Purchase volume and expenditures of included antibacterial agents in April to December 2018 and April to December 2019

From: The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis

Categories

Volume (million DDDs)

Expenditures (million RMB)

Apr. to Dec.

2018

Apr. to Dec.

2019

Relative

change (%)

Apr. to Dec.

2018

Apr. to Dec.

2019

Relative

change (%)

Cefuroxime

1.75

3.38

92.9

5.19

4.21

-18.9

Winning products

1.13

3.20

182.9

1.62

3.29

102.4

Non-winning products

0.62

0.18

-70.3

3.56

0.92

-74.1

Alternatives

7.71

10.04

30.2

87.49

105.89

21.0

Total

9.47

13.42

41.8

92.67

110.09

18.8